Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139
Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139
Price:
22.93
CNY
-0.3%
Market Closed
Market Cap:
¥2.3B
Relative Value
The Relative Value of one
Shaanxi Kanghui Pharmaceutical Co Ltd
stock under the Base Case scenario is
16.71
CNY.
Compared to the current market price of 22.93 CNY,
Shaanxi Kanghui Pharmaceutical Co Ltd
is
Overvalued by 27%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
16.71
CNY
Overvaluation 27%
Multiples Across Competitors
Competitors Multiples
Shaanxi Kanghui Pharmaceutical Co Ltd Competitors
Shaanxi Kanghui Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shaanxi Kanghui Pharmaceutical Co Ltd
SSE:603139
|
2.3B CNY | 4.5 | -12.5 | -18.3 | -18.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD | 16 | 51.5 | 34.6 | 37.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.6B GBP | 5.1 | 31.5 | 15.1 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD | 4.5 | 15.1 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
224.1B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13 | 9.1 | 10.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
